Title Immunotherapy drug which could stall lung cancer for up to five years and even CURE it will now be funded by the NHS Media name/outlet Mail Online Media type Web Country/Territory United Kingdom Date 28/03/19 Description Corinne Faivre-Finn, an oncology professor at the University of Manchester, said: 'The availability of durvalumab is a watershed moment for lung cancer in England as it will change how we treat patients with stage 3 disease.
'Stage three non-small cell lung cancer is potentially curable but unfortunately with current treatments most patients will progress to advanced disease.
'Now, for the first time in 20 years, we have access to a new treatment option that has been shown to improve survival outcomes.'
URL https://www.dailymail.co.uk/health/article-6856879/Immunotherapy-drug-stall-lung-cancer-five-years-funded-NHS.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 Persons Corinne Faivre-Finn
Research Beacons, Institutes and Platforms